Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Rituximab may cause skin issues, but baricitinib can help improve them.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Ixekizumab has known and some unexpected side effects.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.